Fighting leprosy with artificial intelligence: DAHW and Belle.ai join forces with Senegal’s Ministry of Health and Social Action to detect and combat neglected diseases
January 24, 2024 05:05 ET
|
Belle.ai
DAHW, Belle.ai and Senegal's Ministry of Health will deploy Belle.ai’s smartphone-based skin AI software to help Senegal eliminate leprosy by 2030.
The Waldorf Center for Plastic Surgery Announces a New Partnership
January 22, 2024 15:32 ET
|
The Waldorf Center for Plastic Surgery
PORTLAND, Ore., Jan. 22, 2024 (GLOBE NEWSWIRE) -- The Waldorf Center for Plastic Surgery in Portland is excited to announce a new partnership with Forefront Dermatology Group—a medical team that...
Dupixent® (dupilumab) U.S. Label Updated with Data Further Supporting Use in Atopic Dermatitis with Moderate-to-Severe Hand and Foot Involvement
January 16, 2024 07:00 ET
|
Regeneron Pharmaceuticals, Inc.
Data included from first and only Phase 3 trial specifically evaluating a biologic in this difficult-to-treat population Phase 3 trial showed more than twice as many patients treated with Dupixent...
Stretch Marks Treatment Market to Witness Exponential Growth, Projected to Reach US$ 4.6 Billion by 2033: According to Persistence Market Research, Inc
January 12, 2024 03:34 ET
|
Persistence Market Research
New York, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Market Size & Overview: The Global Stretch Marks Treatment Market experienced a Compound Annual Growth Rate (CAGR) of 4.8% from 2012 to 2022,...
Novartis' Cosentyx Shows Promising Early Progress in Treating Hidradenitis Suppurativa, Poised for Significant Future Adoption at the Expense of AbbVie's Humira
January 10, 2024 15:58 ET
|
Spherix Global Insights
Exton, Pennsylvania, Jan. 10, 2024 (GLOBE NEWSWIRE) -- In late October 2023, the FDA granted approval to Novartis' Cosentyx (secukinumab) for treating hidradenitis suppurativa (HS), marking it as...
The Global Skin Lightening Products Market size is predicted to reach at USD 16.08 billion by 2030, increasing at a CAGR of 5.56% - Straits Research
January 10, 2024 08:30 ET
|
Straits Research
New York, United States, Jan. 10, 2024 (GLOBE NEWSWIRE) -- These skin-lightening procedures lighten the complexion. Getting skin-whitening creams is easy. Skin whitening treatments like lotions,...
Asia-Pacific Scar Management Analysis Report 2023: Market is Expected to Reach $363.4 Million by 2030 - Opportunities in the Emergence of Remote Monitoring and Digital Health Solutions
January 08, 2024 12:33 ET
|
Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Scar Management Market - Analysis and Forecast, 2023-2030" report has been added to ResearchAndMarkets.com's offering.The Asia-Pacific...
STRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 Conference
January 08, 2024 08:00 ET
|
STRATA Skin Sciences, Inc.
HORSHAM, Pa., Jan. 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and...
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
January 05, 2024 08:30 ET
|
Journey Medical Corporation
If approved, DFD-29 has potential to be best-in-class and the only oral medication to address both inflammatory lesions and erythema (redness) from rosacea NDA submission supported by positive Phase...
STRATA Skin Granted Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
January 03, 2024 08:00 ET
|
STRATA Skin Sciences, Inc.
HORSHAM, Pa., Jan. 03, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and...